TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo December 18, 2023 Simon Durack Chief Financial Officer Advanced Health Intelligence Ltd. 71-73 South Perth Esplanade, Unit 5 South Perth, WA 6151 Australia Re: Advanced Health Intelligence Ltd. Form 20-F for the Fiscal Year Ended June 30, 2023 File No. 001-41089 Dear Simon Durack: We have limited our review of your filing to the financial statements and related disclosures and have the following comments. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 20-F for the Fiscal Year Ended June 30, 2023 Item 5. Operating and Financial Review and Prospects A. Operating Results, page 37 1. Please revise your results of operations discussion throughout to include both a qualitative and quantitative discussion of the reasons underlying material changes in each of the line items in your statement of operations, including any offsetting factors. For example, your discussion of revenue simply reiterates information that can be obtained from your financial statements but does not discuss the drivers behind the increase in revenue. Similarly, you have not included a discussion of the change in expenses. Refer to Item 5A of Form 20-F. Simon Durack FirstName LastNameSimon Advanced Health IntelligenceDurack Ltd. Comapany18, December NameAdvanced 2023 Health Intelligence Ltd. December Page 2 18, 2023 Page 2 FirstName LastName Item 15. Controls and Procedures A. Disclosure Controls and Procedures, page 80 2. Please revise to include the conclusion of your chief executive and chief financial officer regarding the effectiveness of your disclosure controls and procedures as of the end of the period covered by the report. Also, revise your current reference regarding the definition of disclosure controls and procedures to refer to Rule 13(a)-15(e). Refer to Item 15(a) of Form 20-F. B. Management's Annual Report on Internal Control over Financial Reporting, page 80 3. We note that you did not include a report of management's assessment regarding internal control over financial reporting "due to a transition period established by the rules of the SEC for newly public companies." Since this is your second Form 20-F filing, these transition rules no longer apply to the company. Please amend your filing to include management's assessment of internal control over financial reporting. Refer to Item 15(d) of Form 20-F. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Megan Akst at 202-551-3407 or Kathleen Collins at 202-551-3499 with any questions. Sincerely, Division of Corporation Finance Office of Technology